Document: NUREG-0800
Document ID: 23331bab-fa00-40fd-8357-d8db908b4532
Document Type: srp
Title: GASEOUS WASTE MANAGEMENT SYSTEM
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML0707/ML070710366.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11.3
CFR Part: 
CFR Title: 

Content:
tion. The SRP is not a substitute for the NRC’s regulations, and compliance with it is not required. However, an applicant is required to identify differences between the design features, analytical techniques, and procedural measures proposed for its facility and the SRP acceptance criteria and evaluate how the proposed alternatives to the SRP acceptance criteria provide acceptable methods of compliance with the NRC regulations. 1. The GWMS should have the capability to meet the dose design objectives and should include provisions to treat gaseous radioactive wastes such that the following is true: A. The calculated annual total quantity of all radioactive materials released from each reactor to the atmosphere will not result in an estimated annual external dose from gaseous effluents to any individual in unrestricted areas in excess of 11.3-6 Revision 3 - March 2007 0.05 mSv (5 mrem) to the total body or 0.15 mSv (15 mrem) to the skin. Regulatory Guides 1.109, 1.111, and 1.112 provide acceptable methods for performing this analysis. B. The calculated annual total quantity of radioactive materials released from each reactor to the atmosphere will not result in an estimated annual air dose from gaseous effluents at any location near ground level which could be occupied by individuals in unrestricted areas in excess of 0.01 cGy (10 millirads) for gamma radiation or 0.02 cGy (20 millirads) for beta radiation. Regulatory Guides 1.109, 1.111, and 1.112 provide acceptable methods for performing this analysis. C. The calculated annual total quantity of radioiodines, carbon-14, tritium, and all radioactive materials in particulate form released from each reactor at the site in effluents to the atmosphere will not result in an estimated annual dose or dose commitment from such releases for any individual in an unrestricted area from all pathways of exposure in excess of 0.15 mSv (15 mrem) to any organ. Regulatory Guides 1.109, 1.111, and 1.112 provide acceptable methods